X37

X-37 is a small pharmaceutical discovery and development company based in South San Francisco, California. With a team of five employees, the company focuses on utilizing advanced artificial intelligence technology from Atomwise, Inc. to revolutionize the drug discovery process. X-37 specializes in discovering novel drug candidates by screening extensive libraries of chemical compounds against specific pharmaceutical targets. Their innovative approach leverages AI to accelerate the identification of promising lead compounds, significantly reducing the time and cost associated with traditional drug development methods. The company operates under a unique LLC structure, enabling flexibility and efficiency in managing individual development programs. This structure allows X-37 to seamlessly explore various options, including partnerships and sales, for each drug candidate they develop. The team at X-37 boasts extensive expertise in identifying high-value pharmaceutical targets and navigating the complexities of pharmaceutical development. For more information about X-37 and their innovative drug discovery solutions, please visit their website at x37.ai.